Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Svastia by Cambridgene: 500 Demo Day Batch 24

54 views

Published on

Using AI genetic screening to personalize cancer therapy and improve treatment outcomes.

Published in: Healthcare
  • Be the first to comment

  • Be the first to like this

Svastia by Cambridgene: 500 Demo Day Batch 24

  1. 1. Genetic Screening For CancerTherapy by Cambridgene
  2. 2. Pain Points CAMBRID GE NE Marty info@cambridgene.com svastia.ai
  3. 3. Why Clinical Trials Fail CAMBRID GE NE Get 2M / 6M Lack Of Patients Why patients respond Lack of Data ? ? ? info@cambridgene.com svastia.ai
  4. 4. Our Solution AI-driven genetic screening CAMBRID GE NE info@cambridgene.com svastia.ai
  5. 5. Cancer Clinical Trials COST PER TRIAL $1.4B 9/10 TRIALS FAIL CAMBRID GE NE info@cambridgene.com svastia.ai
  6. 6. Our Solution 18% COST SAVINGS 26% SUCCESS RATE CAMBRID GE NE info@cambridgene.com svastia.ai
  7. 7. Traction CAMBRID GE NE CUSTOMERS HOSPITAL PARTNER info@cambridgene.com svastia.ai
  8. 8. $38B Market CAMBRID GE NE CANCER CLINICAL TRIALS info@cambridgene.com svastia.ai
  9. 9. Team CAMBRID GE NE Parthiban Vijayarangakannan CEO Prem Achuthan CTO Alexey Larionov Consultant oncologist Anusha Gunasekaran Cloud/Big Data engineer info@cambridgene.com svastia.ai
  10. 10. We Offer Hope To Cancer Patients CAMBRID GE NE svastia.ai info@cambridgene.com

×